Atlas Trials

Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection.

Clinical trial NCT05162495 · UNKNOWN

Trial details

NCT number
NCT05162495
Sponsor
Tera Group
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2022-01-01
Primary completion
2022-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.